Literature DB >> 17874752

[Psychochemicals crossing the wall. The introduction of psychoactive pharmaceuticals in the German Democratic Republic--a perspective from the new historiography of drugs].

Volker Hess1.   

Abstract

In recent years, the development, certification, and marketing of drugs has become an important field of research in the Science Studies. Attempting to analyse the growing complexity of the modern health care market, researchers have focused on the close links between pharmaceutical industry, clinical research, and drug regulation in Western Europe and North America. However, corresponding developments behind the Iron Curtain have received little attention. This article outlines a research project that analyses the history of psychoactive pharmaceuticals in East Germany from the perspective of the new historiography of drugs. The paper summarizes the central themes of recent research, provides an overview of the development of the major pharmaceutical substances, and surveys the history of these substances in the GDR in relation to drug legislation and state control of the pharmaceutical market.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17874752

Source DB:  PubMed          Journal:  Medizinhist J        ISSN: 0025-8431


  3 in total

1.  [On the history of the German Democratic Republic Journal Psychiatry, Neurology and Medical Psychology (1949-1990)].

Authors:  M Teitge; E Kumbier
Journal:  Nervenarzt       Date:  2015-05       Impact factor: 1.214

2.  The role of the State Security Service (Stasi) in the context of international clinical trials conducted by western pharmaceutical companies in Eastern Germany (1961-1990).

Authors:  Rainer Erices; Andreas Frewer; Antje Gumz
Journal:  PLoS One       Date:  2018-04-02       Impact factor: 3.240

Review 3.  [The introduction of antipsychotics in the neurological psychiatric hospital of the University of Leipzig and their effects on other forms of therapy, the length of stay and transferrals].

Authors:  Christian Oeser; Holger Steinberg
Journal:  Nervenarzt       Date:  2021-01       Impact factor: 1.214

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.